Shukra Pharmaceuticals Current Share Price | Shukra Pharmaceuticals Stock Screener
SHUKRAPHAR
Pharmaceuticals
Shukra Pharmaceuticals Current Stock Price Today
Live Share Price NSE
₹55.93
▲
1.69 (3.12%)
Live Share Price BSE
₹55.96
▲
1.70 (3.13%)
As of September 18, 2026, the live Shukra Pharmaceuticals share price (NSE: SHUKRAPHAR) is ₹55.93 on NSE and ₹55.96 on BSE, up 3.12% from the previous close, with shares trading between ₹54.29 and ₹57.89 in today's trading session, and a 52-week range of ₹41.42–₹56.10.
Browse Shukra Pharmaceuticals financial data to support your investment research.
Use the Shukra Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Shukra Pharmaceuticals Market Cap
₹2,371.28 Cr.
SHUKRAPHAR P/E Ratio (TTM)
70.03
Shukra Pharmaceuticals P/B Ratio
23.72
EPS (TTM)
₹0.50
Dividend Yield
0.02%
Debt to Equity
0.06
SHUKRAPHAR 52 Week High
₹56.10
Shukra Pharmaceuticals 52 Week Low
₹41.42
Operating Margin
81.00%
Profit Margin
54.17%
SHUKRAPHAR Revenue (TTM)
₹24.00
EBITDA
₹20.00
Net Income
₹13.00
Total Assets
₹117.00
Total Equity
₹90.00
Shukra Pharmaceuticals Current Share Price Chart
Track the current Shukra Pharmaceuticals share price and stock price with an interactive chart. Analyse SHUKRAPHAR price trends, trading volume, historical performance, and volatility across different timeframes — the complete Shukra Pharmaceuticals stock quote in one place.
Shukra Pharmaceuticals Company Profile - Fundamental Screener
Screen Shukra Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHUKRAPHAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE551C01044
Shukra Pharmaceuticals Balance Sheet Screener
Screen SHUKRAPHAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 117 | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 |
| Current Assets | 84 | 65 | 56 | 53 | 16 | 16 | 15 | 11 | 8 | 7 |
| Fixed Assets | 34 | 19 | 20 | 20 | 18 | 18 | 17 | 16 | 14 | 10 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 5 | 7 | 6 | 7 | 6 | 13 | 11 | 9 | 6 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 90 | 63 | 58 | 25 | 16 | 16 | 15 | 15 | 15 | 15 |
| Share Capital | 44 | 44 | 11 | 4 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves & Surplus | 46 | 19 | 47 | 21 | 15 | 14 | 14 | 14 | 13 | 13 |
Shukra Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Shukra Pharmaceuticals income statement and profit fundamentals.
Analyze SHUKRAPHAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shukra Pharmaceuticals share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec |
|---|---|---|---|---|---|---|---|
| Revenue | 24 | 7 | 40 | 8 | 7 | 15 | 12 |
| Expenses | 4 | 6 | 12 | 6 | 4 | 6 | 7 |
| EBITDA | 20 | 2 | 28 | 1 | 2 | 9 | 5 |
| Operating Profit % | 81.00% | 11.00% | 69.00% | -7.00% | 24.00% | 55.00% | 37.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 18 | 0 | 27 | 0 | 1 | 8 | 4 |
| Tax | 5 | 2 | 7 | -2 | 0 | 2 | 1 |
| Net Profit | 13 | -2 | 20 | 2 | 1 | 5 | 3 |
| EPS | 0.30 | -0.04 | 0.47 | 0.05 | 0.02 | 0.12 | 0.72 |
Shukra Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SHUKRAPHAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 8 | -5 | 3 | 8 | 1 | 1 | 0 | 1 | 0 | 3 |
| Investing Activities | -1 | -1 | -4 | -2 | -2 | -3 | -3 | -5 | -1 | 0 |
| Financing Activities | -5 | 12 | 5 | -7 | 2 | 2 | 2 | 4 | 0 | -1 |
| Net Cash Flow | 2 | 6 | 4 | 0 | 0 | 0 | 0 | -1 | -1 | 1 |
Shukra Pharmaceuticals Shareholding Pattern Screener
See Shukra Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Shukra Pharmaceuticals promoter holding and ownership changes for SHUKRAPHAR on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2026-Aug | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.96% | 50.96% | 51.15% | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.37% | 9.38% | 9.34% | 9.29% | 28.69% | 9.20% | 9.43% | 9.79% |
| Other Holding | 39.56% | 39.55% | 39.39% | 39.64% | 20.24% | 39.72% | 39.50% | 39.14% |
| Shareholder Count | 27,173 | 28,384 | 28,384 | 18,231 | 20,337 | 21,441 | 25,649 | 12,974 |
Shukra Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Shukra Pharmaceuticals dividend history with payout and yield data.
View Shukra Pharmaceuticals dividend details including ex-dates and amounts for SHUKRAPHAR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.01 | 0.03% |
| 2024-March | ₹1.00 | 4.58% |
| 2023-March | ₹0.50 | 6.13% |
| 2022-March | ₹0.50 | 42.74% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.50 | 208.33% |
| 2018-March | ₹0.50 | 263.16% |
| 2017-March | ₹0.50 | 156.25% |
Shukra Pharmaceuticals Stock Index Membership
See which indices include Shukra Pharmaceuticals stock.
Check SHUKRAPHAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shukra Pharmaceuticals Market Events Screener - Corporate Actions
Get Shukra Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Shukra Pharmaceuticals stock events that may affect SHUKRAPHAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | 22.29% |
| 2026-09-22 | 2026-09-22 | Annual General Meeting | NA | 3.87% |
| 2026-09-21 | 2026-09-21 | Dividend | ₹ 0.01 /share | 60.44% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 23.79% |
| 2026-07-06 | 2026-07-06 | Extraordinary General Meeting | NA | 2.92% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 13.62% |
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | -7.11% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.17% |
| 2025-11-01 | 2025-11-01 | Extraordinary General Meeting | NA | 19.04% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 34.10% |
| 2025-09-18 | 2025-09-18 | Dividend | ₹ 0.01 /share | 126.55% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -9.76% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -5.08% |
| 2025-03-21 | 2025-03-21 | Split | 1:10 | 5.12% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.64% |
Shukra Pharmaceuticals Competitors Screener - Peer Comparison
Screen SHUKRAPHAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Shukra Pharmaceuticals Company Announcements - News Screener
Screen SHUKRAPHAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-11 | Reg. 34 (1) Annual Report. | - |
| 2026-09-11 | AGM NOTICE | - |
| 2026-09-09 | Update On Date Of AGM | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-09-02 | Board Meeting Outcome for Allottment Of Preference Shares | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-27 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-08-22 | Board Meeting Outcome for AGM And Change Of Name | - |
| 2026-08-17 | Media Release | - |
| 2026-08-17 | Board Meeting Intimation for AGM | - |
| 2026-08-14 | Reg 30 NSE Listing Done | - |
| 2026-08-14 | Reg 30 Change Of Name In Object | - |
| 2026-08-14 | Reg 30 | - |
| 2026-08-14 | Media Release | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Quarterly Results June 30 2026 | - |
| 2026-08-12 | Board Meeting Outcome for Quartely Results June 30 2026 | - |
| 2026-08-06 | Update on board meeting | - |
| 2026-07-30 | Board Meeting Intimation for Quarterly Results | - |
| 2026-07-14 | Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday July 14 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR) | - |